Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
SyncThink logo — Pioneering neuro-technology with advanced eye-tracking for r...

SyncThink

Pioneering neuro-technology with advanced eye-tracking for reliable concussion diagnostics.

Founded 2009 11-50 employees Seed Total: $3.60M Biotechnology, Health Care +3

General Information

Company Name SyncThink
Founded Year 2009
Founders / Decision Makers
Team member
Employees 11-50
Industries Biotechnology, Health Care, Medical Devices +2
Funding Stage Seed
Social

Get notified when SyncThink moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About SyncThink

SyncThink is a pioneering neuro-technology startup with a focus on advanced eye-tracking for reliable concussion diagnostics. Established in 2009 by Dr. Jamshid Ghajar, the company is headquartered in Palo Alto, CA, with an affiliate office in New York City. SyncThink has forged top-tier alliances with esteemed research institutions such as the Brain Trauma Foundation, Stanford University, Mass General Hospital, and the Pac-12. Notably, the company has secured over $36 million in R&D funding through contracts from the US Department of Defense since 2008. The company's flagship product, the EYE-SYNC device, is an all-in-one, head-mounted eye-tracking system designed for rapid and reliable attention focus screening. It boasts multiple FDA-approved applications, with potential uses in neuro-diagnostics in military and sports, children's attention development, brain performance enhancement, fatigue evaluation, and pharmaceuticals. The proprietary technology behind EYE-SYNC comprises eleven issued patents and six pending, covering various aspects of their hardware, analytics, and scientific platform. Notably, the last investment, a Seed Round investment at 11 March 2019, was made by StartUp Health. The EYE-SYNC device has received FDA approval and offers benefits such as quick results (under 60 seconds), accuracy, portability, and established metrics. Overall, SyncThink's innovative approach and strategic collaborations position it as a key player in the biotechnology, healthcare, and pharmaceutical industries, with potential for substantial impact in neuro-technology and concussion diagnostics.

Taxonomy: Neuro-technology, Eye-tracking, Concussion diagnostics, Medical devices, FDA approval, Research and development, Brain trauma, Military applications, Athletic diagnostics, Attention development, Brain performance enhancement, Fatigue evaluation, Pharmaceutical applications, Digital health, Neuroscience

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 1
Investor
11 Mar 2019
Seed Round •••••• 3
Investor
•••• •••• 		10 Jan 2018
Grant •••••• 1
Investor
13 Jun 2017
Seed Round •••••• 2
Investor
•••• •••• 		01 Jan 2011

SyncThink Alternatives & Competitors

SyncThink vs
AdHawk Microsystems
AdHawk Microsystems Canada

AdHawk Microsystems delivers full-stack eye tracking technology - from custom silicon to cloud-based...

Debt Financing
44 employees
Gaming, Hardware
Compare SyncThink vs AdHawk Microsystems
SyncThink vs
Axxonet
Axxonet India

Integrity First

25 employees
Analytics, Cloud Infrastructure
SyncThink vs
Eyeware
Eyeware Switzerland

AI-powered head and eye tracking software that supercharges webcams and 3D sensors on any device

Series Unknown
7 employees
AI, API

FAQ About SyncThink

Pioneering neuro-technology with advanced eye-tracking for reliable concussion diagnostics.
SyncThink was founded in 2009.
SyncThink operates in the following industries: Biotechnology, Health Care, Medical Devices, Pharmaceutical, VR/AR.
SyncThink has approximately 11-50 employees.
SyncThink has completed 4 funding rounds, raising a total of $3.60M. The latest funding stage is Seed.
Top alternatives and competitors to SyncThink include AdHawk Microsystems, Axxonet, Eyeware, TALi, INTA Systems. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SyncThink and AdHawk Microsystems are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors SyncThink and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy